ATI-2138 Outperforms Ritlecitinib in Reversal Model of Alopecia Universalis, the Most Severe AA Phenotype -WAYNE, Pa., (GLOBE ...

Aclaris Therapeutics reported early study results showing its ATI-2138 drug drove rapid and lasting hair regrowth, outperforming Pfizer's Litfulo in a severe hair loss mouse model.

TAMPA (BLOOM) – Alopecia Universalis (AU) stands as one of the most severe forms of hair loss, yet it remains shrouded in mystery. This condition doesn’t just result in the loss of scalp hair but ...

The findings add confidence to the role of ritlecitinib as a treatment option for severe alopecia areata while pointing the way toward more personalized approaches. The kinase inhibitor ritlecitinib ...

TAMPA (BLOOM) – Bloom Health Club is honored to welcome the insightful Analis Bailey, a seasoned journalist, as our special guest in an enlightening episode. Bailey, who has courageously shared her ...